Back for good

Posted:
16
June 2004

RPL is delighted to welcome Clinical Trials Assistant, Bibbi Jilka back to the company after a short spell at Parexel. Bibbi first joined RPL in 2002, having previously worked with Managing Director, Dr Jörg Täubel and Medical Director, Ulrike Lorch at another company. She returned to RPL after just seven months at Parexel.‘I missed RPL's warm friendly environment. It is really exciting to work within a multidisciplinary team with direct access to the Medical Director and the Head Nurse. I am learning all the time and making the most of my training.’In the turn the RPL Directors are pleased to have Bibbi back. Jörg Täubel said, ‘it's very rewarding to hear that RPL offers a stimulating work environment. We want to develop staff to their maximum potential with good training and as much encouragement as possible. We've known Bibbi for a long time and it's great to have her back.’

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more